Reaction
Infusion Site Urticaria reporting signals
As of the last recalculation, Infusion Site Urticaria appears in 650 FAERS reports alongside 26 co-occurring drug terms. The strongest observed disproportionality signal is HUMAN IMMUNOGLOBULIN G (PRR 119.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Human Immunoglobulin G | 69 | 119.7 | 120.1 |
| Diphenhydramine Hydrochloride Capsule, Liquid Filled | 46 | 74.1 | 74.3 |
| Adrenalinum | 74 | 64.3 | 64.4 |
| Diphenhydramine | 89 | 52.1 | 52.2 |
| Epinephrine | 91 | 51.6 | 51.7 |
| Lidocaine | 78 | 48.5 | 48.6 |
| Lidicaine | 58 | 41.6 | 41.6 |
| Burn Relief | 58 | 41.6 | 41.6 |
| Lidocaine Hydrochloride And Epinephrine | 58 | 41.5 | 41.6 |
| Lidocaine, Menthol | 58 | 41.0 | 41.1 |
| Diphenhydramine Hydrochloride | 161 | 41.0 | 41.0 |
| Lidocaine Hydrochloride | 65 | 38.3 | 38.3 |
| Lidocaine Hydrochloride And Epinephrine Bitartrate | 58 | 38.1 | 38.2 |
| Lidocaine 4% | 59 | 38.0 | 38.1 |
| Azelastine | 14 | 25.5 | 25.5 |
| Iron Sucrose | 7 | 23.8 | 23.8 |
| Rizatriptan Benzoate | 7 | 22.3 | 22.3 |
| Hydroxyzine Hydrochloride | 9 | 22.2 | 22.2 |
| Hydroxyzine Hydrochloride Oral | 9 | 22.2 | 22.2 |
| Agalsidase Beta | 5 | 17.4 | 17.5 |
| Riociguat | 16 | 16.1 | 16.1 |
| Levocetirizine Dihydrochloride | 11 | 14.9 | 14.9 |
| Treprostinil | 49 | 13.4 | 13.4 |
| Budesonide, Glycopyrrolate, And Formoterol Fumarate | 4 | 12.3 | 12.3 |
| Fremanezumab-Vfrm | 3 | 8.4 | 8.4 |
| Rimegepant Sulfate | 3 | 7.6 | 7.6 |